Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 14 of 14 entries
Sorted by: Best Match Show Resources per page
Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function.

Oncotarget

Hebert L, Bellanger D, Guillas C, Campagne A, Dingli F, Loew D, Fievet A, Jacquemin V, Popova T, Jean D, Mechta-Grigoriou F, Margueron R, Stern MH.
PMID: 29069806
Oncotarget. 2017 Aug 03;8(42):72513-72527. doi: 10.18632/oncotarget.19872. eCollection 2017 Sep 22.

The tumor suppressor BAP1 associates with ASXL1/2 to form the core Polycomb complex PR-DUB, which catalyzes the removal of mono-ubiquitin from several substrates including histone H2A. This complex also mediates the poly-deubiquitination of HCFC1, OGT and PCG1-α, preventing them...

Cite
Hebert L, Bellanger D, Guillas C, et al. Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function. Oncotarget. 2017;8(42):72513-72527doi: 10.18632/oncotarget.19872.
Hebert, L., Bellanger, D., Guillas, C., Campagne, A., Dingli, F., Loew, D., Fievet, A., Jacquemin, V., Popova, T., Jean, D., Mechta-Grigoriou, F., Margueron, R., & Stern, M. H. (2017). Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function. Oncotarget, 8(42), 72513-72527. https://doi.org/10.18632/oncotarget.19872
Hebert, Lucie, et al. "Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function." Oncotarget vol. 8,42 (2017): 72513-72527. doi: https://doi.org/10.18632/oncotarget.19872
Hebert L, Bellanger D, Guillas C, Campagne A, Dingli F, Loew D, Fievet A, Jacquemin V, Popova T, Jean D, Mechta-Grigoriou F, Margueron R, Stern MH. Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function. Oncotarget. 2017 Aug 03;8(42):72513-72527. doi: 10.18632/oncotarget.19872. eCollection 2017 Sep 22. PMID: 29069806; PMCID: PMC5641149.
Copy Download .nbib Format: NLM
Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective.

Cancers

Gentric G, Mechta-Grigoriou F.
PMID: 33499022
Cancers (Basel). 2021 Jan 22;13(3). doi: 10.3390/cancers13030399.

During the past decades, metabolism and redox imbalance have gained considerable attention in the cancer field. In addition to the well-known Warburg effect occurring in tumor cells, numerous other metabolic deregulations have now been reported. Indeed, metabolic reprograming in...

Cite
Gentric G, Mechta-Grigoriou F. Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective. Cancers (Basel). 2021;13(3)doi: 10.3390/cancers13030399.
Gentric, G., & Mechta-Grigoriou, F. (2021). Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective. Cancers, 13(3), . https://doi.org/10.3390/cancers13030399
Gentric, Géraldine, and Mechta-Grigoriou, Fatima. "Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective." Cancers vol. 13,3 (2021). doi: https://doi.org/10.3390/cancers13030399
Gentric G, Mechta-Grigoriou F. Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective. Cancers (Basel). 2021 Jan 22;13(3). doi: 10.3390/cancers13030399. PMID: 33499022; PMCID: PMC7865797.
Copy Download .nbib Format: NLM
Showing 13 to 14 of 14 entries